Charles M. Warden
Lead Independent DirectorMr. Charles M. Warden is a Co-Founder and CEO at Aquea Health Inc. Mr. Warden serves as the Managing Director of Versant Venture Management, LLC. Mr. Warden joined Versant Ventures in July 2004. He also has served as the President and Chief Executive Officer of Aquea Health, Inc. a medical device company he co-founded, since January 2020. He also works closely with entrepreneurial device companies from inception along the path to success. Mr. Warden was an Advisor at The Innovation Factory, LLC and had been actively involved with since its beginnings in 1999. He is also involved in ForSight Labs. Prior to joining Versant, he served as a General Partner at SV Life Sciences Advisers, LLC. He joined SV Life Sciences in 1996 and led the SV medical device effort. He focused on medical device companies and healthcare service investments and was instrumental in building and leading the medical device franchise for SV Life Sciences. Prior to that, Mr. Warden worked at Boston Capital Ventures, where he concentrated on medical device and other healthcare investments. Prior to this, he was a Consultant at Monitor Clipper Partners, LLC. He has been an Independent Director of Ocular Therapeutix, Inc. since 2008 and had been its Chairman since August 2019 until February, 2024 and serves as its Lead Independent Director from February 2024. He has focused on investing in medical devices since entering the venture capital business in 1992. Mr. Warden serves as a Director of ForSight VISION5, Inc. HALSCION, INC. Celula, Inc. Cotera, Inc. Twelve, Inc. GluMetrics, Inc. ForSight VISION4, Inc, Ceterix Orthopedics, Inc. and WaveTec Vision Systems, Inc. He served as a Director of Concentric Medical, Inc. since December 2003. He served on the Boards of numerous medical device companies. Mr. Warden served as a Director of Insulet Corporation, Acufocus, Inc. The Foundry, LLC, MicroMed Cardiovascular, Inc. Technology, Confluent Surgical Inc. CardioFocus, Inc. Cerebral Vascular Applications, Inc. Liposonix, Neovista, Sadra Medical, Inc. Heritage Health Systems and Medicis Technologies Corporation. Prior to Versant, he was a General Partner at Schroder Ventures Life Sciences (now SV Life Sciences), where he worked from 1996 to 2004. He has been an active medical device venture investor since 1992. Mr. Warden holds an M.B.A. from Harvard Business School and a B.A. in Economics from Beloit College.
Positions
- Company NameOcular Therapeutix, Inc.Stock CodeOCULPositionLead Independent DirectorColleagues
- PUPravin U. DugelExecutive Chairman, President & CEO
- DNDonald NotmanChief Operating Officer (Leave of Absence)
- SMSteve MeyersChief Commercial Officer
- NKNadia K. WaheedChief Medical Officer
- JRJason RobinsCFO & Principal Accounting Officer
- RLRichard L. LindstromIndependent Director
- LJLeslie J. WilliamsIndependent Director
- MRMerilee RainesIndependent Director
